Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology symbols : NVAX save search
Labaton Keller Sucharow LLP Announces Proposed Settlement on Behalf of Purchasers of Lordstown Motors Corp. Securities - RIDE RIDEW
Published: 2024-04-05 (Crawled : 13:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -4.77%
H: 3.3%
C: 0.68%
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
Published: 2024-04-01 (Crawled : 12:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -1.03%
H: 0.62%
C: -3.53%
covid-19 candidate vaccine congress world
Labaton Keller Sucharow LLP and Entwistle & Cappucci LLP Announce Notice of Pendency of Stockholder Class Actions and Proposed Settlement for All Record and Beneficial Owners of Pattern Energy Group Inc. Common Stock as of March 16, 2020
Published: 2024-03-18 (Crawled : 14:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.95%
H: 2.48%
C: -1.91%
energy group
Novavax to Participate in TD Cowen's 44th Annual Health Care Conference
Published: 2024-02-29 (Crawled : 21:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 3.04%
H: 8.06%
C: 5.89%
conference health care
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-02-28 (Crawled : 15:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -22.92%
H: 1.29%
C: -4.96%
year financial results
Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement
Published: 2024-02-22 (Crawled : 11:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 12.06%
H: 22.42%
C: 9.42%
covid-19 vaccine reach agreement
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 0.0%
H: 1.68%
C: -0.72%
conference year financial results
Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 15:30) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: -2.2%
conference
Novavax's Updated COVID-19 Vaccine Now Authorized in Canada
Published: 2023-12-05 (Crawled : 21:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 0.18%
H: 3.93%
C: -0.36%
covid-19 authorized vaccine canada
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
Published: 2023-11-28 (Crawled : 11:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 1.1%
H: 5.07%
C: 3.8%
covid-19 vaccine health world
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Published: 2023-11-17 (Crawled : 12:30) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.17%
H: 2.41%
C: -1.55%
HSIC | $70.21 -1.42% -1.44% 1.1M
|
Distribution Services
|
| O: 0.57%
H: 0.4%
C: -0.58%
Novavax to Participate in Jefferies London Healthcare Conference
Published: 2023-11-10 (Crawled : 14:30) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.45%
H: 0.15%
C: -6.59%
conference
Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights
Published: 2023-11-09 (Crawled : 14:30) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 1.91%
H: 8.08%
C: -3.17%
financial results
Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023
Published: 2023-11-02 (Crawled : 15:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.71%
H: 3.88%
C: 2.73%
conference financial results
Novavax's Updated COVID-19 Vaccine Now Approved in the EU
Published: 2023-10-31 (Crawled : 21:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 0.6%
H: 5.22%
C: 4.48%
covid-19 vaccine approved
Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU
Published: 2023-10-31 (Crawled : 17:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.46%
H: 5.24%
C: 2.62%
covid-19 chmp vaccine positive
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
Published: 2023-10-18 (Crawled : 13:30) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.78%
H: 2.5%
C: 1.09%
covid-19 vaccine prototype approval
Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United Kingdom
Published: 2023-10-18 (Crawled : 12:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.78%
H: 2.5%
C: 1.09%
covid-19 vaccine prototype authorization
Novavax COVID-19 Vaccine Doses Available at Major Retail Pharmacies Across the U.S.
Published: 2023-10-13 (Crawled : 13:30) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: -4.73%
covid-19 vaccine retail
Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023
Published: 2023-10-11 (Crawled : 14:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 0.68%
H: 9.29%
C: 2.69%
europe vaccine congress world technology
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.